Key result
Coronary vasomotor function testing protocols vary widely in vascular domains tested, provocative agents, and measurement techniques, highlighting the lack of a standardized diagnostic approach.
Why the study?
Although diagnostic criteria for endotypes of coronary vasomotor dysfunction exist, consensus on a standardised coronary vasomotor function testing protocol is lacking.
The lack of consensus on a standardized coronary vasomotor function testing protocol hampers widespread clinical adoption and may lead to differing diagnoses of coronary vasomotor dysfunction endotypes across specialized centers.
Protocol variability risks discrepant diagnoses across centers; leaves open consensus standardization for reproducible research and care.
BACKGROUND: Coronary vasomotor dysfunction can be diagnosed in a large proportion of patients with angina in the presence of non-obstructive coronary artery disease (ANOCA) using comprehensive protocols for coronary vasomotor function testing (CFT). Although consensus on diagnostic criteria for endotypes of coronary vasomotor dysfunction has been published, consensus on a standardised study testing protocol is lacking. AIMS: In this review we provide an overview of the variations in CFT used and discuss the practical principles and pitfalls of CFT. METHODS: For the purposes of this review, we assessed study protocols that evaluate coronary vasomotor response as reported in the literature. We compared these protocols regarding a number of procedural aspects and chose six examples to highlight the differences and uniqueness. RESULTS: Currently, numerous protocols co-exist and vary in vascular domains tested, the manner in which to test these domains (e.g., preprocedural discontinuation of medication, provocative agent, solution, infusion time, and target artery) and techniques used for measurements (e.g., Doppler vs thermodilution technique). CONCLUSIONS: This lack of consensus on a uniform functional testing protocol hampers both a broader clinical acceptance of the concepts of coronary vasomotor dysfunction, and the widespread adoption of such testing protocols in current clinical practice. Furthermore, the endotype of coronary vasomotor dysfunction might differ among the few specialised centres that perform CFT as a result of the use of different protocols.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a review in Angina and non-obstructive coronary arteries (ANOCA). Coronary vasomotor function testing (CFT) was evaluated. Coronary vasomotor function testing protocols vary widely in vascular domains tested, provocative agents, and measurement techniques, highlighting the lack of a standardized diagnostic approach.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: